IL1B and Parkinson disease: PD and T2D share chronic, low-grade inflammation as a common pathophysiological mechanism with increased levels of serum CRP, TNF-α, interferon-γ, interleukin-1β (IL-1β), IL-2, and IL-6, [83,263,267].